Man Group
BXRX

Man Group’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Man Group’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9
Closed -$52K – 1919
2020
Q2 		$52K Buy
+9
New +$43.2K ﹤0.01% 1644

Other funds holding BXRX

NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Man Group's BXRX Position: Q3 2020 in Review

Man Group sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q3 2020, closing a stake of 9 shares — an estimated $52K sold.

Man Group first reported a position in BXRX in Q2 2020 and held it in 1 quarter. The position peaked at $52K in Q2 2020. 26 funds tracked by Wall St. Rank hold BXRX as of Q3 2020.

  • Man Group reported no remaining Baudax Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Man Group sold 9 Baudax Bio, Inc. Common Stock shares in Q3 2020, an estimated $52K.
  • Man Group first reported a position in Baudax Bio, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Man Group's Baudax Bio, Inc. Common Stock position peaked at $52K in Q2 2020.
  • 26 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q3 2020.

Based on Man Group's 13F filing for Q3 2020, filed 16 Nov 2020.